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Abstract: We have attempted to define the prevalence and risk factors of extended-spectrum
beta-lactamase-producing Enterobacteriaceae (ESBL-Enterobacteriaceae) carriage, and to characterize
antimicrobial susceptibility, beta-lactamase genes, and major types of isolated strains in volunteers,
with a specific focus on humans in contact with animals. Samples were collected from 207 volunteers
(veterinarians, pig farmers, dog owners, etc.) and cultured on selective agar. Clonal relationships
of the isolated ESBL-Enterobacteriaceae were determined by whole genome sequencing and
multi-locus sequence typing. Beta-lactamases were detected using a homology search. Subjects filled
in questionnaires analyzed by univariate and multiple logistic regression. Colonization with
ESBL-Enterobacteriaceae was found in fecal samples of 14 individuals (6.8%; 95%CI: 3.75–11.09%).
In multiple regression analysis, working as a pig farmer was a significant risk factor for
ESBL-Enterobacteriaceae carriage (OR 4.8; 95%CI 1.2–19.1). The only species isolated wasEscherichia coli
that distributed into 11 sequence types. All ESBL-Enterobacteriaceae isolates were of CTX-M genotype,
with the blaCTX-M-1 being the most prevalent and more common in pig farmers than in other groups.
Despite the generally low prevalence of ESBL-Enterobacteriaceae in Estonia, the pig farmers may still
pose a threat to transfer resistant microorganisms. The clinical relevance of predominant blaCTX-M-1
carrying E. coli is still unclear and needs further studies.
Keywords: ESBL; Escherichia coli; healthy volunteer; one health; CTX-M; whole genome sequencing
1. Introduction
The prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae
(ESBL-Enterobacteriaceae) has continuously increased in both hospitals and communities all
over the world [1,2]. Its frequency varies widely (2–70%) and depends on geographical location [3–5].
These trends have been mainly associated with the spread of the highly pathogenic multi-resistant
Escherichia coli ST131 carrying blaCTX-M-15 in healthcare institutions [6,7].
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Traditionally, Estonia is regarded as region with a low antibiotic resistance similar to other
Northern European countries. However, there is a trend showing that resistance rates of some
enterobacterial species to 3rd generation cephalosporins have significantly increased over the last
10 years [8].
Mucosal colonization usually precedes invasive infection. Therefore, monitoring mucosal
colonization provides an indication of antimicrobial resistance (AMR) rates in a country. A large
variability in ESBL-Enterobacteriaceae colonization in Estonia′s neighboring countries, namely Latvia
and Russia (1.6% vs. 23.3%, respectively) were found in a recent study by Ny et al. [3]. Thus,
the importance of local knowledge is crucial when planning measures to tackle antibiotic resistance.
The carriage of ESBL-Enterobacteriaceae out-side the healthcare system has been associated
with travel to high prevalence countries [9–11], as well as contact with pets or farm animals through
occupation as food handlers or farmers. In recent years more and more data emerge on importance of
cross species transmission of AMR [12,13]. It has been suggested that the digestive tract of livestock
and poultry is a significant reservoir of multi-resistant bacteria. Thus, this may serve as a possible
source of human colonization through either direct contact with animals or contaminated food chain
and thus deserves further investigation [1,14,15].
Since 2000, Enterobacteriaceae producing CTX-M-ESBL has been predominant, with a wide
genetic variability amongst humans outside the hospital, i.e., in the community. Certain geographical
links have shown that blaCTX-M-15 is more prevalent in Europe, Africa, Middle East and South Asia,
whereas blaCTX-M-14 is dominates in the Western Pacific Region [6,7,16]. In the Estonian clinical setting
blaCTX-M-15 has also been dominating [17]. Unfortunately, data regarding beta-lactamase genes of
ESBL-Enterobacteriaceae strains outside hospitals is still lacking.
A new successful blaCTX-M type has emerged in recent years and has further confused the situation.
Thus, blaCTX-M-27 was firstly discovered in France and has been considered as a single nucleotide
variant of blaCTX-M-14 [18]. As blaCTX-M-15 and blaCTX-M-14 are mainly found in humans, blaCTX-M-27 and
blaCTX-M-1 occur in many species, making cross-species transmission likely and transmission between
different environments possible [14].
We hypothesized that colonization by ESBL-Enterobacteriaceae is greater in people in contact
with farm animals or pets than in general population and that this carriage may be associated
with human disease. Thus we aimed (i) to evaluate the extent of ESBL-Enterobacteriaceae carriage
in otherwise healthy people, with a particular focus on those who are in contact with animals,
(ii) analyze phenotypic antimicrobial resistance, beta-lactamase genes, and major subtypes of
circulating strains, and (iii) attempted to characterize possible risk factors associated with acquisition
of ESBL-Enterobacteriaceae.
2. Material and Methods
2.1. Study Design
This prospective study was a part of the research project “Transfer routes of antibiotic resistance”
in Estonia (ABRESIST). All procedures were carried out in accordance with the ethical standards of
the Research Ethics Committee of the University of Tartu (approvals 213/T-11 and 241/M-16 23th of
April 2012), and in keeping with the 1964 Helsinki declaration and its later amendments, at comparable
ethical standards. Informed consent was obtained from all individual participants (or their guardians)
included in the study.
From 30th of April 2012 to 11th December 2013 we approached four groups of people as follows.
First, we contacted veterinarians via the official mailing lists of the Estonian Small Animal Veterinary
Association and Estonian Veterinary Association; second, we contacted pig farms with more than
1000 animals to recruit pig farmers; third, we approached dog owners via a website of Animal Clinic
of the Estonian University of Life Sciences and finally we recruited subjects who should represent
Estonian community. For that patients admitted for elective orthopedic surgery or in pediatric wards of
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the Tartu University Hospital were contacted if they were older than six months, had no antimicrobial
treatment or hospitalization in the previous three months and time since hospitalization was of <48 h.
Three former groups were those with contact to animals and the fourth group (patients) represented the
general population. Each subject was included once and only one person per a household was recruited.
After signing an informed consent all subjects provided samples and filled in a questionnaire about
their demographics (age, gender) and factors possibly influencing ESBL-Enterobacteriaceae carriage
(occupation, main source of food and drinking water, smoking, travel together with destination in
previous year, eating outside the home, contact with pets or farm animals, and antibacterial treatment
and hospitalization in the previous 12 months).
2.2. Sample Collection and Analysis
Nasal swabs and stool samples were either self-collected (dog owners and veterinarians)
following detailed instructions or sampled by the trained personal (pig farmers and control group).
Nasal specimens were taken using swabs with transport medium (Transystem, COPAN, Italy) and
2–3 g of feces was taken with specialized spoon and placed into a container (Aptaca, Canelli, Italy).
All samples were immediately transported to the microbiology laboratory of the University of Tartu and
stored at −80 ◦C for a maximum of 2 months. If quick transportation was not available, samples were
stored at −20 ◦C for a maximum of 48 h.
Thawed nasal swabs were plated onto blood agar and incubated at 37 ◦C for 24–48 h in ambient
air. All colonies with different morphology were isolated and identified using MALDI-TOF mass
spectrometry (Bruker Daltonics, Bremen, Germany).
Defrosted fecal samples were plated on selective medium for isolation of ESBL-producing
organisms (BrillianceTM ESBL Agar, Oxoid, Basingstoke, UK) and incubated at 37 ◦C for 24 h. Then two
colonies per plate with morphology suggestive of Escherichia coli or the Klebsiella, Enterobacteria, Serratia,
and Citrobacter group (KESC) were selected and confirmed at species level using MALDI-TOF mass
spectrometry (Bruker Daltonics, Bremen, Germany).
2.3. Antimicrobial Susceptibility Testing
All isolated Enterobacteriaceae were tested for ESBL production by measuring ceftazidime,
cefotaxime and cefepime minimal inhibitory concentrations (MIC) alone and in combination with
clavulanic acid (Etest, bioMérieux, Marcy l’Etoile, France). The Etest was also used to test additional
susceptibility of ESBL-positive strains to meropenem, piperacillin/tazobactam, gentamicin, amikacin,
ciprofloxacin, TMP/SMX, fosfomycin, and tigecycline. The quality control strain routinely used was
E. coliATCC® 25922™. EUCAST breakpoints and definitions were used to interpret susceptibility [19,20].
2.4. DNA Extraction
DNA of the isolated ESBL-Enterobacteriaceae strains was extracted from single colonies grown on
blood-agar using a modified GuSCN-silica protocol [21]. Briefly, cells were transferred to a solution
containing 570 µL TRIS-EDTA buffer (pH 7.6). Then, 30 µL 10% SDS with ~0.5 g zirconium beads
(0.1 mm diameter) was added and the mixture processed for 5 min on bead beater (Minibead beater,
Bio Spec Products, Bartlesville, DA, USA), followed by centrifugation at 10,000 rpm for 1 min.
Lysis involved combining the supernatant with 900 µL lysis buffer L6 (5.25 M GuSCN, 100 mM
Tris—HCl pH 6.4, 20 mM EDTA, 1.3% Triton X-100) and 40 µL custom-prepared silica suspension.
The mixture was incubated for 5 min at room temperature before being centrifuged at 5000 rpm for
10 s. The supernatant was discarded, and the pellet washed with 1000 µL buffer L2 (5 M GuSCN) and
1000 µL 50% ethanol. The silica pellet was briefly dried, and the DNA eluted with ultra-pure water
(milli-Q). The extracted DNA was stored at −20 ◦C until analysis.
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2.5. Whole Genome Sequencing
Total bacterial DNA was quantified using a Qubit® 2.0 Fluorometer (Invitrogen, Grand Island,
NE, USA) and 2200 TapeStation (Agilent Technologies, Santa Clara, CA, USA). Ten ng sample
DNA was processed with an Illumina Nextera XT sample preparation kit (Illumina, San Diego, CA,
USA). The resulting DNA libraries were validated by qPCR using a Kapa Library Quantification Kit
(Kapa Biosystems, Woburn, MA, USA) to optimize cluster generation.
Then, 23 ssDNA Nextera XT libraries originating from 23 different clones were pooled and
sequenced in one rapid-output run of a HiSeq2500 (Illumina, San Diego, CA, USA), with paired-end
150-bp reads. Demultiplexing used CASAVA 1.8.2. (Illumina, San Diego, CA, USA), allowing one
mismatch in the index reads.
2.6. Draft Assembly of Whole Genome Sequences (WGS), in Silico Multi-Locus Sequence Typing (MLST) and
Phylogeny Analysis
All Illumina reads were assembled de novo using the SPAdes genome assembler (ver 3.5.0)
together with the MismatchCorrector [22].
A BLAST-based tool from https://cge.cbs.dtu.dk/services/MLST/ was run to annotate the MLST
fragments within the WGS data [23]. Sequence type (ST) identification was done with the mlst software
(Seemann T, https://github.com/tseemann/mlst) using MLST schemes from the PubMLST website
(https://pubmlst.org/) [24].
Core genomes were aligned using parsnp tool from Harvest suite v1.1.2 [25]. Thereafter,
recombinations in the core genomes were detected using BratNextGen software [26]. For phylogenetic
analysis, recombination-free alignments were created by masking all significant recombinant segments
as missing data in the input alignment. These alignments were used to reconstruct a maximum
likelihood phylogenetic tree with RaxML using the GTR-GAMMA model [27].
As core genome alignment and MLST analysis resulted in similar clustering, the data are presented
according to STs of MLST.
2.7. Testing for Resistance Genes
Beta-lactamases were detected using a homology search against the ResFinder database.
Contigs containing ESBL-genes were further analyzed using BLAST [28] against the NCBI nt/nr
databases to specify possible relation to known plasmid sequences and to check for the presence of
mobile elements near the ESBL-genes.
2.8. Statistical Analysis
Statistical analysis used Stata 14.2 [29]. As a pilot study, the sample size of volunteers was not
formally calculated. Descriptive statistics are presented as a comparison of ESBL-Enterobacteriaceae
carriers and non-carriers. Following exploratory variables were used in univariate analysis:
age, gender, occupation, the main source of milk products, fruit and vegetables, meat and
drinking water; owning domestic animals, owning a dog, owning a cat, owning farm animals,
travelling abroad, travelling abroad to Europe, travelling outside Europe, smoking, eating outside
the home, antibiotic treatment and hospitalization in previous year. Factors that were statistically
significant in univariate analysis (p < 0.05) were included in multiple logistic regression analysis
to determine independent risk factors associated with the colonization of ESBL-producing strain.
As variance inflation factor (VIF = 10.81) indicated multicollinearity between travelling in Europe
and travelling in general, the travelling in Europe was excluded from multiple regression analysis.
The bottled water category was excluded from further analysis as it consisted of only 5 participants
(2%). Likelihood ratio test and Akaike information criterion were used to determine by backward
selection the best final model. The final model included occupation and travelling as independent
variables. A Chi square goodness of fit test was used, for final model Chi(2) = 2.94, p = 0.230.
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Availability of data and materials: The datasets used and/or analyzed during the current
study available from the corresponding author on reasonable request. All WGS data have been
deposited into the NCBI (PRJNA311519; Accession numbers: JABUFH000000000, JABUFI000000000,
JABUFJ000000000, JABUFK000000000, JABUFL000000000, JABUFM000000000, JABUFN000000000,
JABUFO000000000, JABUFP000000000, JABUFQ000000000, JABUFR000000000, JABUFS000000000,
JABUFT000000000, JABUFU000000000, JABUFV000000000, JABUFW000000000, JABUFX000000000,
JABUFY000000000, JABUFZ000000000, JABUGA000000000, JABUGB000000000, JABUGC000000000,
JABUGD000000000).
3. Results
3.1. Study Population
We contacted 200 veterinarians and 63 pig farms of which 29 (14.5%) and nine (14.3%),
respectively agreed to participate. A total of 207 individuals were recruited—29 veterinarians,
29 pig farmers (one to five per farm), 80 dog owners and 69 individuals in the control group.
Majority of the subjects were female (n = 144; 70%), with a median age of 40 years
(range 6 months–82 years); 46 (22%) were aged <18 years.
Colonization with ESBL-Enterobacteriaceae occurred only in fecal samples. Altogether 14
(6.8%; 95%CI: 3.75–11.09%) individuals were colonized, namely seven (24.1%; 95% CI: 10.3–43.54%)
pig farmers, two (6.9%; 95% CI 0.84–22.77%) veterinarians, one (1.3%; 95% CI: 0.03–6.7%) dog owner,
and four (5.8%; 95% CI: 1.60–14.18%) in the control group. The only isolated ESBL-Enterobacteriaceae
species was E. coli.
3.2. Risk Factors of ESBL-Enterobacteriacae Carriage
Comparison of ESBL-Enterobacteriaceae positive and negative subjects is presented in Table 1.
Table 1. Association between carriage of ESBL-Enterobacteriaceae and risk factors/clinical
characteristics.
ESBL-Enterobacteriaceae Carriage Univariate Analysis
Negative
(n = 193)
Positive
(n = 14) OR (95%CI) p-Value
Male sex (%) 56 (29) 7 (50) 2.4 (0.8–7.3) 0.109
Age: median (range) 40 (0–82) 47 (3–64) NA
Occupation (%)
Other/not working a
Veterinarian
Pig farmer
141 (73.1)
30 (15.5)
22 (11.4)
5 (35.7)
2 (14)
7 (50)
1
1.9 (0.3–10.1)
9.0 (2.6–30.8)
0.463
<0.001 *
Source of food b
Milk products (%)
Purchased from market/shop
Own produce/local farmer
Meat (%)
Purchased from market/shop
Own produce/local farmer
Fruit and vegetables
Purchased from market/shop
Own produce/local farmer
154 (82.4)
33 (17.7)
156 (80.8)
34 (17.9)
93 (48.2)
98 (51.3)
10 (71.4)
4 (28.6)
11 (78.6)
3 (21.4)
2 (14.3)
12 (85.8)
1
1.9 (0.5–6.3)
1
1.2 (0.3–4.7)
1
5.7 (1.2–26.1)
0.316
0.741
0.025 *
Source of the drinking water (%)
Central water supply
Well
Bottled water
Various sources
128 (67.0)
55 (28.8)
3 (1.6)
5 (2.6)
6 (42.8)
6 (42.9)
2 (14.3)
0 (0)
1
2.3 (0.7–7.5)
14.2 (2.0–101.7)
NA
0.159
0.008 *
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Table 1. Cont.
ESBL-Enterobacteriaceae Carriage Univariate Analysis
Negative
(n = 193)
Positive
(n = 14) OR (95%CI) p-Value
Smoking (%) 21 (10.9) 4 (28.6) 3.3 (0.9–11.3) 0.063
Owning domestic animals (%)
Dog
Cat
Farm animals c
150 (77.7)
126 (65.3)
92 (47.7)
21 (10.9)
10 (71.4)
8 (57.1)
8 (57.1)
2 (14.3)
0.7 (0.2–2.4)
0.7 (0.2–2.1)
1.5 (0.5–4.3)
1.3 (0.3–6.5)
0.589
0.539
0.495
0.697
Travel abroad in past 12 months (%)
Europe
Outside Europe
110 (57)
105 (54.4)
17 (8.8)
3 (21.4)
3 (21.4)
2 (14.3)
0.2 (0.1–0.8)
0.2 (0.1–0.8)
1.7 (0.4–8.4)
0.018 *
0.023 *
0.498
Eating outside home (%) d
Few times (<3 times) a year/never
Frequently (≥3 times a month)
90 (46.9)
102 (53.1)
11 (78.6)
3 (21.4)
1
0.2 (0.1–0.9) 0.033 *
Antibacterial treatment in previous year (%) 53 (27.5) 2 (14.3) 2.3 (0.5–10.5) 0.293
Hospitalization in previous year (%) 21 (11.1) 0 (0) NA
* Statistically significant (p < 0.05). a Occupational data were initially assigned to five different categories – healthcare
worker, veterinary personal, (pig) farmer, food industry worker (exposure to raw meat, unpasteurized milk or
unprocessed eggs or both), and another status including the unemployed. As some groups (healthcare workers, food
industry workers) were small (seven and three persons, respectively), they were combined with other/unemployed
group in further analysis. b Subjects who reported that they do not consume this type of food were removed from
analysis. Accordingly 6 people were removed from milk product, 3 people from meat and 2 people from fruit and
vegetable source analysis.c Cattle, swine d 1 person who did not answer the question was excluded from analysis.
According to univariate analysis, occupation as a pig farmer, consumption of self- or local
farmer produced vegetables, drinking bottled water, and eating mainly at home were associated with
ESBL-Enterobacteriaceae carriage. Traveling in Europe turned out as a protective factor. All statistically
significant variables from univariate analysis were included in multiple regression analysis to exclude
possible cofounders.
The multiple logistic regression model showed that the only independent predictor of colonization
with ESBL-Enterobacteriaceae was occupation as a pig farmer compared to the “other/not working”
group (OR 4.8; 95%CI 1.2–19.1).
3.3. Phylogenetic Grouping, Antimicrobial Susceptibility and ESBL Encoding Genes
In total, 23 ESBL-Enterobacteriaceae strains were obtained. We aimed to isolate at least two strains
from each participant, but this was not feasible in five cases due to poor growth of the isolates.
All strains isolated from the selective medium showed positive ESBL production in confirmatory
E-tests. Four of the 23 ESBL producing strains were resistant to three different antibiotic
groups—non-susceptibility to trimethoprim-sulfamethoxazole being the most common (11 out of
23 strains; Figure 1).
As all MIC values to meropenem were under 0.125 mg/L, carbapenemase production was not
tested [30].
In MLST analysis, the strains distributed into 11 sequence types (ST). Only two STs were identified
in more than one person (both ST10 and ST131, with two strains from two individuals each) (Figure 1).
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Figure 1. Main characteristics of ESBL-Enterobacteriaceae hosts (n = 14) and strains (n = 23). A maximum likelihood core genome tree and MLST analysis; presence of
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As shown in Figure 1, blaCTX-M genes were isolated in all ESBL-Enterobacteriaceae strains,
whereas only one strain carried blaTEM gene. Three types of CTX-M class genes were identified.
BlaCTX-M-1 (13 strains from 9 individuals) was the most common followed by blaCTX-M-15 (8 strains from
4 individuals) and blaCTX-M-14 (2 strains from 1 individual). BlaCTX-M-1 producing Enterobacteriaceae
were more frequently found in pig farmers than in other populations (7/29; 24.1% vs. 2/178; 1.1%) while
blaCTX-M-14 and blaCTX-M-15 only occurred in other populations and not in pig farmers. Most of the ESBL
gene containing contigs had mobile elements in the vicinity of bla-genes (21/23 blaCTX-M, Figure 2) and
contained several other plasmid related genes suggesting possible plasmid origin. No carbapenemase
encoding genes were found.
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length of the genes nd intergenic s quences.
4. Discussion
In the first study conducted in Estonia looking at the colonization of ESBL-Enterobacteriaceae in the
population, of whom majority had contact with pets and/or farm animals, we found: (1) that the carriage
of ESBL-Enterobacteriaceae was rel tively low in most groups except ig farmers; (2) accordingly
the only i dependent risk factor for ESBL-Enterobacteriaceae colonizati n was working as a pig
farmer; (3) all ESBL-positive isolates were E. coli; (4) the most pr valent ESBL gene was blaCTX-M-1,
isolated pred minantly from pig fa mers; (5) the spread of ESBL-Enterobacteriace e was allodemic
rather than epidemic or endemic, and (6) the co-resistance rate among ESBL-Enterobacteriaceae strains
was low, except to TMP/SMX.
The reported prevalence of ESBL-Enterobacteriaceae, varies significantly across the world,
ranging between 1.6% in Latvia to 70% in some provinces of China and Thailand [3,7,31,32].
Geographic variances might have developed mainly due to different antibiotic policies and hygiene
standards in both human medicine and animal husbandry, but also of the level of access to basic
sanitation and clean water. The latter contributes to the formation and transmission of resistance
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reservoirs between environments [6]. Our finding of 6.8% of fecal carriage of ESBL-Enterobacteriaceae
in total is in concordance with reports from other Northern European countries with rates between 4.7
and 6.6% [3,33,34]. This result was fairly predictable considering Estonia’s good sanitation level and
prudent antibiotic consumption strategies in human medicine [35].
Although overall antibiotic usage in veterinary medicine is low, the proportion of 3rd and 4th
generation cephalosporins, however, is exceptionally high. Estonia holds the first place in Europe
on this. The latter is of concern as extensive use of 3rd and 4th generation cephalosporins in animal
husbandry has been suggested to increase the development and transmission of blaCTX-M genes from
farm animals (poultry, pigs, cattle) to the human population [6].
Our findings of significantly higher colonization rate of ESBL-Enterobacteriaceae among pig
farmers (24.1%) than in any the other groups (3.9%), including dog owners and veterinarians support
previous studies indicating that contact to pigs is a risk factor for acquiring ESBL-Enterobacteriaceae [36].
This prevalence is much higher than in other European countries such as the Netherlands, Germany and
Denmark, in which the carriage rates of farm workers have been similar to the general population
(2.5 to 13%) [36–39]. Rates similar to ours have been reported in China (20%) where colonization with
ESBL-Enterobacteriaceae in healthy non-animal exposed humans was also very high, reaching up
to 70% and carriage rate in pigs is reported above 60% [4,40]. In contrast to farmers, the phenotypic
resistance to 3rd generation cephalosporins isolated from pigs in Estonia has been reported as
low, i.e., 2.5% and 3.3% in healthy and 4.2% and 7.7% in diseased animals, for cefotaxime and
ceftazidime, respectively [41]. Interestingly no ESBL-Enterobacteriaceae strains were identified from
animals or environment of the farms where workers with ESBL-Enterobacteriaceae carriage were detected
(unpublished preliminary data).
As the transmission of methicillin-resistant staphylococci from pigs to humans has been well
described, evidence of a role of contact with pigs in human ESBL-Enterobacteriaceae colonization is
still limited. Direct contact with pigs is assumed to be the main transmission route, and carriage rate
depends on the contact intensity and pig ESBL-Enterobacteriaceae status, but further discussions have
led to a possible connection with farm air contamination and inhalation of resistant enterobacteria or
their genetic elements by workers, followed by carriage in the nostrils [37,38,42,43]. Similar to Fischer
et al., we did not find any ESBL-Enterobacteriaceae in volunteers’ nares, making this hypothesis not
well justified.
The predominance of blaCTX-M-1 is an unusual finding in the community-based studies,
as blaCTX-M-15 dominates in human studies in other Nordic countries and Germany and blaCTX-M-14
in Mexican, Portuguese and Asian volunteers [5,6,10,32,34,44–46]. BlaCTX-M-1 is the most frequent
ESBL-gene in livestock, and transmission of this lineage from animals through food or via direct contact
with farm animals (including pigs) has been described [6,37,38,43].
The role of blaCTX-M-1 in causing human disease remains unclear as it is rarely found in clinically
relevant samples of hospitalized patients in Estonia or elsewhere [47,48]. Even if blaCTX-M-1 carrying
isolates have been found as clinically relevant, it has occurred in Germany and the Netherlands,
both countries having large-scale intensive farming [6,14].
We found an allodemic spread pattern rather than a single-clone epidemic as 11 different sequence
types of ESBL-producing E. coli was carried by 14 volunteers. Similar to previous studies in healthy
volunteers, there was no dominance of ST131, indicating that each carrier has its strain and that
ESBL transfer from one person to another in the non-closed community is unlikely, with only genetic
fragments (like beta-lactamase coding genes) being transmitted [7,10].
As blaCTX-M containing plasmids often involve cassettes encoding resistance to multiple
antibiotic classes, the multiresistant phenotype is typical in these strains [1,6]. We did not observe
multi-resistance, but almost half of the isolates (47.8%) were resistant to TMP/SMX, similar to a previous
multi-country study of Ny et al. (2018). At the same time, the most frequently described co-resistance
in ESBL-producing isolates, resistance to ciprofloxacin, from 10% in Norwegian to 65% in Russian
volunteers, was at the lower end in our strains (8.7%) [3,34].
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A few limitations should be noted. We must emphasize first that we specifically recruited
groups of individuals who had contact with animals. Second, we excluded patients with a history of
hospitalization and antibiotic treatment in the previous three months, the latter being a well-known
risk factor for the development and spread of antimicrobial resistance. Thus, the preselected group
may not necessarily be fully representative of the general Estonian population. As this was a pilot
study, no formal sample size calculation was performed. Still, we believe that the number of subjects
should be sufficient to draw preliminary conclusions and suggestions for further studies.
5. Conclusions
The prevalence of ESBL-Enterobacteriaceae in the Estonian community is generally low except
among pig farmers. Working as a pig farmer is an independent risk factor for the acquisition of
ESBL-Enterobacteriaceae, suggesting a possible transfer of antibiotic-resistant strains from pigs to
humans. The clinical relevance of this transfer, however, is less clear as the majority of human infections
have been related to CTX-M-14 or CTX-M-15 genotypes, and not to the CTX-M-1 genotype that was
found in pig farmers in our study.
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